Crescent Grove Advisors’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$396K Sell
3,853
-700
-15% -$79K 0.04% 198
2025
Q4
$570K Buy
4,553
+1
+0% +$127 0.05% 166
2025
Q3
$610K Sell
4,552
-23
-0.5% -$3.02K 0.06% 156
2025
Q2
$622K Sell
4,575
-2,244
-33% -$296K 0.06% 149
2025
Q1
$904K Buy
6,819
+301
+5% +$38.3K 0.09% 110
2024
Q4
$737K Buy
6,518
+1,886
+41% +$218K 0.07% 131
2024
Q3
$528K Sell
4,632
-634
-12% -$69.5K 0.05% 158
2024
Q2
$547K Buy
5,266
+500
+10% +$53K 0.06% 157
2024
Q1
$542K Sell
4,766
-149
-3% -$17.1K 0.06% 173
2023
Q4
$541K Buy
4,915
+10
+0.2% +$999 0.06% 163
2023
Q3
$475K Buy
4,905
+143
+3% +$15K 0.06% 178
2023
Q2
$519K Buy
+4,762
New +$508K 0.06% 168
2022
Q1
Sell
-1,701
Closed -$239K 293
2021
Q4
$239K Buy
+1,701
New +$218K 0.02% 264
2021
Q3
Sell
-1,763
Closed -$204K 269
2021
Q2
$204K Buy
1,763
+74
+4% +$8.63K 0.02% 247
2021
Q1
$202K Buy
+1,689
New +$200K 0.02% 200

Other funds holding ABT

Crescent Grove Advisors's ABT Position: Q1 2026 in Review

Crescent Grove Advisors reduced its Abbott (ABT) stake by 15% in Q1 2026, selling an estimated $79K and leaving 3,853 shares worth $396K. The position accounts for 0.04% of the portfolio, ranked #198.

Crescent Grove Advisors first reported a position in ABT in Q1 2021 and has held it in 15 quarters since. The position peaked at $904K in Q1 2025. 3,087 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Crescent Grove Advisors held 3,853 shares of Abbott worth $396K as of Q1 2026.
  • Crescent Grove Advisors sold 700 Abbott shares in Q1 2026, an estimated $79K.
  • Abbott made up 0.04% of Crescent Grove Advisors's portfolio in Q1 2026, its #198 holding.
  • Crescent Grove Advisors first reported a position in Abbott in Q1 2021 and has held it in 15 quarters since.
  • Crescent Grove Advisors's Abbott position peaked at $904K in Q1 2025.
  • 3,087 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Crescent Grove Advisors's 13F filing for Q1 2026, filed 6 May 2026.